Mary Nauffal

Clinical Pharmacy Specialist- BMT @MSKCancerCenter l PGY-2 @DanaFarber l PGY-1 @BrighamWomens

[IHOP SA @IHOPsa]

من منظور عالمي، ناقش Dr. Derek Stewart و Dr. Mary Nauffal في جلسة Pharmacy in Next Level كيف تقود القيادة المهنية التأثير الإكلينيكي، وترتقي بالممارسة الصيدلانية إلى مستويات أكثر تقدمًا #TedHop

[Dana-Farber @DanaFarber]

Congratulations to Joseph Antin, MD, recipient of the @ASTCT Lifetime Achievement Award. This recognition is given to a physician who has made continuing contributions to the BMT and cellular therapy fields through the advancement of knowledge through basic or clinical science.

https://t.co/es1uyusSbL

[Victor Nauffal @nauffal_victor]

Incredibly fortunate and grateful to be mentored by @patrick_ellinor and to work with world class scientists @broadinstitute @broad_ml4h. More to come!

[Victor Nauffal @nauffal_victor]

Our work examining the biologic pathways underlying fibrosis in the heart now out @NatureGenet
Condensed summary: https://t.co/wT9WzjIhrd
Full article: https://t.co/kidKgiRsyu
@steven_lubitz @patrick_ellinor @broad_ml4h @broadinstitute @mghcvrc @bwhcvls
Main findings in 🧵👇

[Mary Nauffal @MaryNauffal]

@DrMiguelPerales @MSKCancerCenter @SSRaj017 @ASTCT Congratulations Sandeep! @SSRaj017 👏👏👏 Well deserved

[Mary Nauffal @MaryNauffal]

Are you or someone you know interested in pursuing a PGY-2 Oncology Residency at Memorial Sloan Kettering? Please join us for our virtual recruitment sessions below. Follow the link or QR code to learn more: https://t.co/HU1rljW2cj.

[Mary Nauffal @MaryNauffal]

@ChristineRyanMD @CllSociety @DrMDavids @DanaFarber Congratulations @ChristineRyanMD 👏👏👏 super proud!

[Mary Nauffal @MaryNauffal]

Proud to be part of a continuously recognized and admired cancer center! @MSKCancerCenter

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

At MSK we treat more than 400 types of cancer – including the most important one: yours. We are proud to be recognized for this work by @usnews for the past 33 years. And we are so grateful to our patients for continually trusting us with their care.

[Victor Nauffal @nauffal_victor]

Excited to share our work delineating the monogenic and polygenic contributions to QTc prolongation in the population @CircAHA https://t.co/rxIvJEiZz0 @valerie_morrill @JurgensSean @patrick_ellinor @steven_lubitz Detials in accompanying 🧵:

[Victor Nauffal @nauffal_victor]

Just out @medrxivpreprint, first large-scale GWAS of myocardial fibrosis measured by native T1 in the human heart https://t.co/H8LmVE1A5r
Product of great collaboration @paolodkl @MarcusKlarqvist @JonWCunningham @jpirruccello & mentorship @gpbatra @patrick_ellinor @steven_lubitz

[Mary Nauffal @MaryNauffal]

Defibrotide real-world experience:
Encouraging responses for #VOD after MAC and RIC allogeneic #HCT. Early diagnosis, prompt initiation and minimizing dose interruptions may be key to successful treatment of VOD/ SOS. Link: https://t.co/xYCr7TQElz. @romeerizwan @BloodAdvances

[PTCE @PharmacyTimesCE]

Join faculty Rebecca Borgert, PharmD, BCOP, and Mary Nauffal, PharmD, MS, BCOP, as they showcase how CAR T-cell therapies fit into the treatment paradigm for patients with hematologic malignancies and explore strategies to improve patient access to care. https://t.co/EQA6qtvQNb

[Martin S. Tallman, MD @MartinTallman]

Oct is American Pharmacists Month. Invaluable members of the healthcare team whose role has never been more important: drug-drug interactions, monitoring drug levels, novel drug toxicities, pt educa, clinical trials, etc. They deserve our thanks. @ASH_hematology @pharmacists

[Mary Nauffal @MaryNauffal]

In shock and disbelief of the news.
Thank you Dr. Marty for all that you taught me and your immeasurable contributions to science. You will be dearly missed and so grateful to have worked with you! @FranciscoMarty_

[Brigham and Women’s Infectious Diseases @bwh_id]

Devastated by the loss of our friend, colleague, and mentor Dr. Francisco Marty. We are inspired to read all of the ways Dr. Marty touched clinicians, scientists, and most of all patients all over the world. His dedication and generosity will not be forgotten.

[Brigham and Women’s Infectious Diseases @bwh_id]

Devastated by the loss of our friend, colleague, and mentor Dr. Francisco Marty. We are inspired to read all of the ways Dr. Marty touched clinicians, scientists, and most of all patients all over the world. His dedication and generosity will not be forgotten.

[Mary Nauffal @MaryNauffal]

Our observation that defibrotide may cause low positive results of betaglucan after allogeneic #HCT

[Francisco Marty, MD @FranciscoMarty_]

Quick fact based on astute observations from Dr. Brett Glotzbecker, now @ClevelandClinic, @Sara_Alosaimy @MaryNauffal, @davidwkubiak: #debrifrotide contains #BetaGlucan and can cause low positive results in patients with #VOD after allogeneic #HCT

link:https://t.co/OCiv6SoF3B

[Mary Nauffal @MaryNauffal]

Congratulations to the most dedicated person I know @nauffal_victor! Truly well deserved. Love you!#Proudsister

[Mary Nauffal @MaryNauffal]

Our recent work: https://t.co/0Zlgq0OLJv

[CardioNerds @CardioNerds]

📽️Let's get started‼️

@DeepakAtriMD & @nauffal_victor, @BrighamFellows, former @OslerResidency teach:

✅Virology
✅Molecular basis for new Rx
☑️Epidemiology
☑️Clinical Presentation

https://t.co/ymGPgO0vDJ
https://t.co/xZ3LuTUGeg
https://t.co/nNFLsVjDAo
https://t.co/zlY72Cd4rf